Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma

NCT00793845 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Cyclophosphamide
DRUG: Etoposide
DRUG: Carboplatin
DRUG: Thiotepa
DRUG: Melphalan
RADIATION: Total body irradiation

Sponsor

Samsung Medical Center